• Published On: January 25, 2018
    10MD receives CE mark approval for HeadPeace

    10MD gains market access for HeadPeace with the CE mark approval from the Notified Body.

  • Published On: December 4, 2017
    HeadPeace clinically validated

    In a clinical study performed by researchers at Sahlgrenska University Hospital and Halland Regional Hospital, it was shown that HeadPeace reduces the radiation dose to body parts that are currently not protected.

  • Published On: November 25, 2017
    10MD in the news (in Swedish)

    Utdrag från MedTechWest artikel

  • Published On: October 31, 2017
    Vinnova supports 10MD

    Vinnova has decided to grant a 10MD application. Medtech4Health, a strategic funding program at Vinnova, has decided to grant a 10MD funding application.

  • Published On: September 28, 2017
    2.6 million SEK project financed by Vinnova

    Vinnova decided to support a 10MD project with a budget of 2.6 million SEK to increase production capacity of TeXray.

  • Published On: July 17, 2017
    Promising results from HeadPeace functionality study

    To minimize cranial exposure to ionizing radiation, 10MD has developed HeadPeace, which has recently proven its functionality and comfortability in clinical studies at Halland Regional Hospital.